ID2 and cancer: Previously the upregulation of SNORD72 has been reported to distinguish cancer from normal counterparts and to promote liver cancer cell invasiveness via stabilizing ID2 mRNA, whereas SNORD92 has been linked to BC patient outcome25,26,48,49.